Buyback Spend for West Pharmaceutical Services (WST)
Buyback Spend for West Pharmaceutical Services (WST): headline value $298.40M · YoY -76.4%. Annual and quarterly series, chart, and tables are below.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingBuyback SpendSwitch metric
Latest period
$298.40M
YoY change
-76.4%
5Y CAGR
+2.0%
Peak year (2024)
$566.60M
Latest annual
$134.00M
Buyback Spend history chart for West Pharmaceutical Services (WST) from 1989 to 2025
Buyback Spend history table for West Pharmaceutical Services (WST) from 1989 to 2025
| Fiscal year | Period ended | Reported | Buyback Spend | YoY |
|---|---|---|---|---|
| 2025 | $134.00M | -76.4% | ||
| 2024 | $566.60M | +25.6% | ||
| 2023 | $451.20M | +103.1% | ||
| 2022 | $222.20M | +46.3% | ||
| 2021 | $151.90M | +25.1% | ||
| 2020 | $121.40M | +42.3% | ||
| 2019 | $85.30M | +20.5% | ||
| 2018 | $70.80M | -4.8% | ||
| 2017 | $74.40M | +33.1% | ||
| 2016 | $55.90M | +898.2% | ||
| 2015 | $5.60M | +36.6% | ||
| 2014 | $4.10M | -21.2% | ||
| 2013 | $5.20M | +10.6% | ||
| 2012 | $4.70M | +34.3% | ||
| 2011 | $3.50M | +66.7% | ||
| 2010 | $2.10M | +61.5% | ||
| 2009 | $1.30M | -75.0% | ||
| 2008 | $5.20M | -87.9% | ||
| 2007 | $43.00M | — | ||
| 2006 | $0 | -100.0% | ||
| 2005 | $100,000 | 0.0% | ||
| 2004 | $100,000 | — | ||
| 2003 | $0 | -100.0% | ||
| 2002 | $100,000 | 0.0% | ||
| 2001 | $100,000 | -99.1% | ||
| 2000 | $10.80M | -40.3% | ||
| 1999 | $18.10M | -70.0% | ||
| 1998 | $60.40M | — | ||
| 1997 | $0 | — | ||
| 1996 | $0 | — | ||
| 1995 | $0 | — | ||
| 1994 | $0 | — | ||
| 1993 | $0 | -100.0% | ||
| 1992 | $3.30M | — | ||
| 1991 | $0 | -100.0% | ||
| 1990 | $11.30M | +113.2% | ||
| 1989 | $5.30M | — |
Buyback Spend values are taken from West Pharmaceutical Services's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2025, West Pharmaceutical Services (WST) buyback spend totalled $134.00M – plunged 76.4% year-over-year.
Over 2020–2025 (5 years), West Pharmaceutical Services buyback spend expanded at a +2.0% compound annual rate, with the latest reading among the more recent periods of the dataset.
West Pharmaceutical Services buyback spend plunged from $566.60M in 2024 to $134.00M in 2025, a 76.4% drawdown.
2024 marks the peak buyback spend at $566.60M, with the historical low of $0 recorded in 1991.
Among 8 Healthcare peers, West Pharmaceutical Services (WST) ranks 8th; the peer median for buyback spend is $2.75B.
West Pharmaceutical Services Buyback Spend by Year
West Pharmaceutical Services Buyback Spend 2025: $134.00M
West Pharmaceutical Services buyback spend in 2025 was $134.00M, plunged 76.4% below 2024.
West Pharmaceutical Services Buyback Spend 2024: $566.60M
West Pharmaceutical Services buyback spend in 2024 was $566.60M, grew 25.6% from 2023. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Buyback Spend 2023: $451.20M
West Pharmaceutical Services buyback spend in 2023 was $451.20M, surged 103.1% from 2022.
West Pharmaceutical Services Buyback Spend 2022: $222.20M
West Pharmaceutical Services buyback spend in 2022 was $222.20M, surged 46.3% from 2021.
West Pharmaceutical Services Buyback Spend 2021: $151.90M
West Pharmaceutical Services buyback spend in 2021 was $151.90M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — Buyback Spend
Companies in the same sector as West Pharmaceutical Services, ranked by their latest buyback spend.
| Company | Buyback Spend | Sector |
|---|---|---|
| Johnson & Johnson (JNJ) | $5.95B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $5.54B | Healthcare |
| Merck & Co., Inc. (MRK) | $5.08B | Healthcare |
| Eli Lilly and Company (LLY) | $4.11B | Healthcare |
| Novo Nordisk A/S (NVO) | $1.39B | Healthcare |
| AbbVie Inc. (ABBV) | $980.00M | Healthcare |
| AstraZeneca PLC (AZN) | $719.66M | Healthcare |
| Amgen Inc. (AMGN) | $0 | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's buyback spend?
Latest reported buyback spend for West Pharmaceutical Services (WST) is $298.40M (period ending March 31, 2026).
How has West Pharmaceutical Services buyback spend changed year-over-year?
West Pharmaceutical Services (WST) buyback spend changed -76.4% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services buyback spend?
West Pharmaceutical Services (WST) buyback spend compound annual growth rate is +2.0% over the most recent 5 years available.
When did West Pharmaceutical Services buyback spend hit its highest annual value?
West Pharmaceutical Services buyback spend reached its highest annual value of $566.60M in 2024.
What was West Pharmaceutical Services buyback spend in 2024?
West Pharmaceutical Services (WST) buyback spend in 2024 was $566.60M.
What was West Pharmaceutical Services buyback spend in 2025?
West Pharmaceutical Services (WST) buyback spend in 2025 was $134.00M.
Metrics overview
Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.